Nicholas Bishop

Partner at Deerfield Management

Vice President, Biotechnology Equity Research
2010 - 2014
Equity research coverage of over 20 companies in the Biotech space. Build financial models, interview physician thought leaders and C-level executives, and evaluate scientific and commercial merit of clinical trial candidates and marketed products in order to develop investment recommendations for institutional long-only and long/short clients. Coverage: AEGR, ALXN, AMGN, ARIA, BMRN, CELG, INCY, ISIS, ONXX, REGN, VPHM, others. Series 7, 63, 86, 87 certified.

Postdoctoral Fellow
2007 - 2010
Alzheimer disease and brain aging. • Led the introduction of a newly discovered technology to the lab, creating a novel model of Alzheimer disease. This project idea formed the basis of a competitive grant proposal (1% of applications successful) that was funded for $1M. • Trained and managed two graduate students in order to expand the scope of this project. • First-authored one peer-reviewed publication in Nature.

Graduate Research Assistant
2000 - 2007
Genetic regulation of aging in C. elegans. • Discovered the first gene controlling longevity caused by food restriction in an animal, also inventing fundamental new experimental techniques in the process. • Presented my results to audiences of over 300 people as an invited speaker at two international scientific conferences. • First-authored one peer-reviewed article in Nature. Article chosen as issue cover story. • First-authored one additional peer-reviewed publication in Nature Reviews Genetics. Paper is now required reading for a graduate-level course at Harvard.